First Targeted Therapy for Rare Form of GI Stromal Tumors

The targeted chemotherapy avapritinib (Ayvakit) has been approved to treat a rare form of gastrointestinal stromal tumor that hasn't been responsive to previous drug therapies.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research